Effects of Static Stretching and Self-myofascial Release on Local and Remote Range of Motion

NCT07213011 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2025-11-19

No results posted yet for this study

Summary

Static stretching and self-myofascial release are commonly used techniques to improve joint mobility, primarily through mechanisms such as reduced tissue stiffness, increased stretch tolerance, and warming effects. Emerging evidence suggests that these interventions may also elicit remote effects, improving range of motion in body segments distant from the site of application. These non-local adaptations are thought to occur via mechanisms such as myofascial force transmission, systemic increases in stretch tolerance, or global neuromuscular responses. This phenomenon may have important clinical implications, particularly in scenarios where direct treatment of a target area is limited due to pain, injury, or immobilization.

Therefore, this study explores the potential for local and remote effects of static stretching and self-myofascial release applied to the right posterolateral neck region. Specifically, this study investigates whether targeted cervical interventions can acutely improve not only cervical range of motion but also hip flexion range of motion on the ipsilateral (right) side. The proposed mechanisms include reductions in tissue stiffness, increased stretch tolerance and pressure pain threshold, and the transmission of mechanical forces along myofascial chains, particularly the "superficial back line," which anatomically connects the cervical region to the posterior lower limb. The primary aim of this study was to compare the acute effects of neck static stretching and neck self-myofascial release using a massage roller on both local (cervical) and remote (right hip) ROM.

Conditions

  • Health
  • Healthy Participants
  • Healthy Subjects
  • Healthy Young People
  • Healthy Young Adults
  • Stretching
  • Myofascial Release
  • Massage Effect

Interventions

OTHER

Neck static stretching

The neck static stretching (SS) protocol consisted of four sets, each lasting 45 seconds, interspersed with 45-second recovery periods (total intervention time: 3 minutes). While seated on a chair, participants performed the stretch by gently inclining the head forward and to the left in an antero-lateral direction and assisting the movement with the contralateral (left) hand to specifically elongate the right posterolateral neck region.

OTHER

Neck self-myofascial release

For the self-myofascial release (SMR) intervention, a Theraband® roller massager was employed. The device consists of a rigid plastic core surrounded by dense foam, designed with a grooved surface to facilitate both superficial and deeper tissue stimulation. The SMR protocol comprised four sets (total intervention time: 3 minutes), during which participants executed 45 rhythmic rolling movements per set at a cadence of one roll per second. The tempo was standardized using a metronome application. For the SMR condition, the protocol included 45-second recovery intervals between sets. Participants, seated on a chair, were instructed to perform self-administered rolling on the right posterolateral neck region using the massage roller and to cover the largest possible area of the posterolateral neck region during the rolling, with the head gently inclined forward and to the left in an antero-lateral direction.

Sponsors & Collaborators

  • University of Palermo

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-05-14
Primary Completion
2025-07-28
Completion
2025-07-28

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07213011 on ClinicalTrials.gov